Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sacituzumab tirumotecan Antibody

Sacituzumab tirumotecan (SKB264) is a TROP2-targeting antibody-drug conjugate that delivers the topoisomerase I inhibitor KL610023 into tumor cells, inducing DNA damage and apoptosis. It is being investigated in preclinical and clinical research for TROP2-positive cancers, including non-small cell lung cancer and triple-negative breast cancer.

Product Specifications

Target

TROP2, Antibody-Drug Conjugates (ADCs)

Conjugation

Unconjugated

Field of Research

Immunology & Inflammation

Concentration

15 mg/mL

Purity

99.00% (May vary between batches)

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL
BNC880034-100 1x 100 µL

Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD7 (T3-3A1), CF740 conjugate, 0.1mg/mL
BNC740978-100 1x 100 µL

CD7 (T3-3A1), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
P27 / KIP1 (SX53G8), CF740 conjugate, 0.1mg/mL
BNC740669-500 1x 500 µL

P27 / KIP1 (SX53G8), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD8 (RIV11), CF555 conjugate, 0.1mg/mL
BNC550333-100 1x 100 µL

CD8 (RIV11), CF555 conjugate, 0.1mg/mL

Sign In for Pricing
View Details